Pharmaceutical - Diabetes

Filter

Current filters:

Diabetes

Popular Filters

126 to 150 of 401 results

Eylea filed for EU and US approval in diabetic macular edema

Eylea filed for EU and US approval in diabetic macular edema

07-11-2013

US biotech firm Regeneron Pharmaceuticals says its partner German drug major Bayer has submitted an application…

BayerDiabetesEuropeEyleaNorth AmericaOphthalmicsPharmaceuticalRegeneronRegulation

Trajenta studies prove efficacy in broad range of diabetes patients

Trajenta studies prove efficacy in broad range of diabetes patients

07-11-2013

Boehringer Ingelheim and Eli Lilly (NYSE: LLY) have released new data that reinforces the efficacy and…

Asia-PacificBoehringer IngelheimDiabetesEli LillyNorth AmericaPharmaceuticalResearchTrajentaUSA

Cardiovascular risk a concern when prescribing diabetes treatments, survey finds

06-11-2013

Boehringer Ingelheim and Eli Lilly (NYSE: LLY) revealed that 79% of nearly 800 physicians in four Asian…

Asia-PacificBoehringer IngelheimDiabetesEli LillyHealthcarePharmaceuticalResearch

Novo Nordisk gains US FDA approval for FlexTouch insulin pens

Novo Nordisk gains US FDA approval for FlexTouch insulin pens

03-11-2013

Danish insulin giant Novo Nordisk announced on Friday that the US Food and Drug Administration has approved…

DiabetesFlexTouchLevemirNorth AmericaNovo NordiskNovoRapidPharmaceuticalRegulation

Novo Nordisk nine-month sales up 13%; takes larger diabetes market share

Novo Nordisk nine-month sales up 13%; takes larger diabetes market share

31-10-2013

Danish insulin giant Novo Nordisk reported sales of 61.9 billion ($11.3 billion) Danish kroner in the…

DiabetesFinancialNovo NordiskPharmaceutical

Novo Nordisk recalls some NovoMix 30 insulin products in Europe

Novo Nordisk recalls some NovoMix 30 insulin products in Europe

27-10-2013

Danish insulin giant Novo Nordisk said on Friday that it is recalling certain batches of its prefilled…

DiabetesEuropeNovo NordiskNovoMixPharmaceuticalRegulation

Chinese, European drugmakers strike $500 million-plus deal

25-10-2013

An agreement worth more than $500 million between privately-held Swiss/Greek pharmaceutical and clinical…

DiabetesEuropeFochon PharmaFosun PharmaLicensingPharmaceuticalResearchSellas Life Sciences

Type 2 diabetes market to reach $38.8 billion by 2019

25-10-2013

The global type 2 diabetes market is expected to expand from $20.4 billion in 2012 to $38.8 billion by…

Boehringer IngelheimDiabetesEli LillyEuropeGemigliptinMarkets & MarketingNesinaNorth AmericaPharmaceuticalTakeda PharmaceuticalsTradjenta

PDL BioPharma secures royalties on diabetes products in $240m deal

PDL BioPharma secures royalties on diabetes products in $240m deal

22-10-2013

PDL BioPharma has acquired the rights to receive royalties and milestones payable on sales of Type 2…

DepomedDiabetesFinancialGlumetzaInvokanaJanumetLicensingmetforminNorth AmericaPDL BioPharmaPharmaceutical

UK’s medicines watchdog recalls five Wockhardt medicines

UK’s medicines watchdog recalls five Wockhardt medicines

18-10-2013

The UK’s Medicines and Healthcare products Regulatory Agency has recalled five medicines made by Indian…

AnalgesiaDiabetesEuropeGliclazidePharmaceuticalProductionRegulationWockhardt

Vivus obesity drug reduces progression to type 2 diabetes in high-risk overweight patients

10-10-2013

New data published on-line in Diabetes Care, today Care demonstrating positive effects of USA-based Vivus’…

DiabetesMetabolicsPharmaceuticalQsymiaResearchVivus

Case study draws attention to innovator brand preferences in Kenya

08-10-2013

Some of the stronger performing brands in Kenya’s pharmaceutical market have been highlighted in a…

Antibiotics and Infectious diseasesCardio-vascularDiabetesGlaxoSmithKlineMarkets & MarketingPharmaceuticalRest of the World

Evolva to license EV-077 to Serodus

07-10-2013

Switzerland-based Evolva Holding and Norwegian biopharma company Serodus have signed a binding term…

BiotechnologyDiabetesEV-077EvolvaLicensingNephrology and HepatologyPharmaceuticalSerodus

Lyxumia plus basal insulin lowers blood sugar, latest data show

Lyxumia plus basal insulin lowers blood sugar, latest data show

05-10-2013

Sanofi has announced new GetGoal-L sub-analysis results showing that reductions in HbA1c with Lyxumia…

DiabetesLyxumiaPharmaceuticalResearchSanofiZealand Pharma

DPP-IV inhibitors use in newly-diagnosed type 2 diabetes patients

03-10-2013

Through analysis of US longitudinal patient-level claims data, dipeptidyl peptidase (DPP-IV) inhibitors…

DiabetesMarkets & MarketingNorth AmericaPharmaceutical

New hypoglycemia and pancreatitis sub-analyses from the Onglyza SAVOR study released at EASD

New hypoglycemia and pancreatitis sub-analyses from the Onglyza SAVOR study released at EASD

27-09-2013

Bristol-Myers Squibb and partner AstraZeneca have announced additional results from the SAVOR cardiovascular…

AstraZenecaBristol-Myers SquibbDiabetesOnglyzaPharmaceuticalResearch

Sanofi strengthens its presence in Algeria with €70 million investment

Sanofi strengthens its presence in Algeria with €70 million investment

26-09-2013

French drug major Sanofi revealed today that construction has begun on its new Sidi Abdellah industrial…

Cardio-vascularDiabetesFinancialPharmaceuticalProductionRest of the WorldSanofi

Geropharm to invest $45 million in Russian insulin production

Geropharm to invest $45 million in Russian insulin production

25-09-2013

Geropharm, one of Russia’s leading pharmaceutical and biotech companies, is establishing a plant for…

DiabetesEli LillyEuropeFinancialGeropharmNovo NordiskPharmaceuticalProductionSanofi

Takeda’s Vipidia for type 2 diabetes gets go-ahead in Europe

Takeda’s Vipidia for type 2 diabetes gets go-ahead in Europe

24-09-2013

Japan’s largest drugmaker Takeda Pharmaceutical has received marketing authorization from the European…

DiabetesEuropePharmaceuticalRegulation

UK CDMO Aesica unveils a new £30m high capacity manufacturing facility

19-09-2013

UK contract development and manufacturing organization (CDMO) Aesica Pharmaceuticals has announced the…

Aesica PharmaceuticalsDiabetesEuropePharmaceuticalProduction

Approved cancer drug potentially could help treat diabetes, Stanford researchers find

16-09-2013

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular…

afliberceptBayerBiotechnologyDiabetesEyleaOncologyPharmaceuticalRegeneronResearchSanofiZaltrap

Pilot project in Ukraine for regulation of insulin preparation pricing

16-09-2013

Last week in the Ukraine, the Association of Pharmaceutical Research and Development (APRaD) and the…

DiabetesEuropePharmaceuticalPricing

126 to 150 of 401 results

Back to top